Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods for treating extreme insulin resistance in patients resistant to previous treatment with other anti-diabetic drugs employing an SGLT2 inhibitor and compositions thereof

US Patent 8685934 · Granted Apr 1, 2014

Estimated economic value: $102,900,000

Assignee

Inventors

View full patent text on Google Patents →